Nogo-B Silencing Expedites the Senescence of Platelet-Derived Growth Factor-BB-Induced Human Hepatic Stellate Cells Via Autophagy
- PMID: 38727882
- DOI: 10.1007/s12033-024-01179-6
Nogo-B Silencing Expedites the Senescence of Platelet-Derived Growth Factor-BB-Induced Human Hepatic Stellate Cells Via Autophagy
Abstract
Liver fibrosis is a severe liver pathology in response to chronic or iterative liver injury. Senescence has emerged as a protective mechanism against liver fibrosis. Nogo-B has been well established as a significant contributor to liver fibrosis. Nonetheless, researches regarding the role of Nogo-B in cell senescence during liver fibrosis are few. In platelet-derived growth factor-BB (PDGF-BB)-treated human hepatic stellate cell line LX-2, cell proliferation was assayed by CCK-8 method. Western blotting estimated the expression of Nogo-B and fibrosis markers. After Nogo-B was silenced in LX-2 cells pretreated by an autophagy activator Rapamycin and PDGF-BB, CCK-8 method was used to assess cell proliferation. Fibrosis was measured by western blotting and immunofluorescence. Cell cycle was subjected to flow cytometry analysis and cell senescence was evaluated by SA-β-gal staining. Immunofluorescence staining assessed autophagy. Nogo-B was elevated in PDGF-BB-exposed LX-2 cells. Nogo-B silencing suppressed the proliferation, fibrosis, and autophagy while induced cell cycle arrest and senescence of LX-2 cells. Additionally, pretreatment with Rapamycin partially restored the effects of Nogo-B knockdown on the autophagy, proliferation, fibrosis, cell cycle, and senescence of LX-2 cells upon exposure to PDGF-BB. Collectively, inactivation of autophagy mediated by Nogo-B deficiency might elicit protective activities against the development of liver fibrosis.
Keywords: Autophagy; Hepatic stellate cells; Liver fibrosis; Nogo-B; Senescence.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis.Bioengineered. 2022 Mar;13(3):6150-6162. doi: 10.1080/21655979.2022.2037841. Bioengineered. 2022. PMID: 35200103 Free PMC article.
-
Cellular crosstalk mediated by platelet-derived growth factor BB and transforming growth factor β during hepatic injury activates hepatic stellate cells.Can J Physiol Pharmacol. 2018 Aug;96(8):728-741. doi: 10.1139/cjpp-2017-0768. Epub 2018 Mar 20. Can J Physiol Pharmacol. 2018. PMID: 29558627
-
Taurine attenuates activation of hepatic stellate cells by inhibiting autophagy and inducing ferroptosis.World J Gastroenterol. 2024 Apr 21;30(15):2143-2154. doi: 10.3748/wjg.v30.i15.2143. World J Gastroenterol. 2024. PMID: 38681990 Free PMC article.
-
Depletion of β-arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway.J Cell Biochem. 2013 May;114(5):1153-62. doi: 10.1002/jcb.24458. J Cell Biochem. 2013. PMID: 23192415
-
The small heterodimer partner inhibits activation of hepatic stellate cells via autophagy.Adv Clin Exp Med. 2020 Jun;29(6):683-693. doi: 10.17219/acem/122175. Adv Clin Exp Med. 2020. PMID: 32598580
References
-
- Lee, Y. A., Wallace, M. C., & Friedman, S. L. (2015). Pathobiology of liver fibrosis: A translational success story. Gut, 64(5), 830–841. - PubMed
-
- Tsochatzis, E. A., Bosch, J., & Burroughs, A. K. (2014). Liver cirrhosis. Lancet, 383(9930), 1749–1761. - PubMed
-
- Bunchorntavakul, C., & Reddy, K. R. (2017). Acute liver failure. Clinics in Liver Disease, 21(4), 769–792. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources